Tenet Healthcare Corporation
NYQ: THCLive Quote
About Tenet Healthcare Corporation
Healthcare
Medical Care Facilities
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
📊 Fundamental Analysis
Tenet Healthcare Corporation demonstrates a profit margin of 6.6%, which is below the sector average, suggesting competitive pressure.
The company recently reported 8.9% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 27.0%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $195.24, THC currently sits at the 62nd percentile of its 52-week range (Range: $109.82 - $247.21).
💰 Valuation Insight
THC trades at a 49.6% discount (PE: 12.61), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
✅
Return on Equity
Excellent
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$14.33B
Trailing P/E
12.61
Forward P/E
11.12
Beta (5Y)
1.50
52W High
$247.21
52W Low
$109.82
Avg Volume
1.08M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App